{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:30:46Z","timestamp":1790951446702,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"am","delay-in-days":258,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.coi.2018.03.025","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T13:25:09Z","timestamp":1523885109000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness"],"prefix":"10.1016","volume":"53","author":[{"given":"Maryna C","family":"Eichelberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Morens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery K","family":"Taubenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2018.03.025_bib0300","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2018.03.025_bib0305","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/cid\/ciw816","article-title":"Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011\u201312 through 2014\u201315","volume":"64","author":"Ferdinands","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2018.03.025_bib0310","first-page":"18","article-title":"Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012\/13 \u2013 a rapid epidemiological and virological assessment","author":"Bragstad","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coi.2018.03.025_bib0315","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","article-title":"Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium","volume":"78","author":"Matrosovich","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0320","doi-asserted-by":"crossref","first-page":"e110026","DOI":"10.1371\/journal.pone.0110026","article-title":"A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2018.03.025_bib0325","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0042-6822(74)90276-1","article-title":"Characterization of temperature sensitive influenza virus mutants defective in neuraminidase","volume":"61","author":"Palese","year":"1974","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.03.025_bib0330","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0042-6822(83)90205-2","article-title":"Effects of hexose starvation and the role of sialic acid in influenza virus release","volume":"125","author":"Griffin","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.03.025_bib0335","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/jvi.2.4.281-288.1968","article-title":"Antiviral activity of antiserum specific for an influenza virus neuraminidase","volume":"2","author":"Kilbourne","year":"1968","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0340","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2018.03.025_sbref0345","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.03.025_bib0350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/jcm.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coi.2018.03.025_sbref0355","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.03.025_bib0360","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1750-2659.2010.00191.x","article-title":"Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection","volume":"5","author":"Easterbrook","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.coi.2018.03.025_bib0365","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.vaccine.2011.01.047","article-title":"Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir","volume":"29","author":"Sultana","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0370","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/jvi.63.3.1239-1246.1989","article-title":"Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection","volume":"63","author":"Johansson","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0375","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/j.vaccine.2012.04.102","article-title":"A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate","volume":"30","author":"Wodal","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0380","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/j.vaccine.2012.01.090","article-title":"The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets","volume":"30","author":"Chen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0385","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine","volume":"87","author":"Rockman","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0390","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01035-10","article-title":"Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets","volume":"84","author":"Bosch","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0395","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/infdis\/jir711","article-title":"A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies","volume":"205","author":"Fritz","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.03.025_bib0400","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.vaccine.2009.12.041","article-title":"A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects","volume":"28","author":"Cate","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0405","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.vaccine.2009.10.066","article-title":"A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses","volume":"28","author":"Hassantoufighi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0410","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant virus like particle influenza A (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2018.03.025_sbref0415","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1128\/JVI.01203-13","article-title":"Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses","volume":"87","author":"Wan","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0042-6822(84)90114-4","article-title":"Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies","volume":"135","author":"Webster","year":"1984","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.03.025_bib0425","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1038\/ncomms7114","article-title":"Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers","volume":"6","author":"Wan","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2018.03.025_sbref0430","first-page":"92","article-title":"Comparison of the efficacy of N9 neuraminidase-specific monoclonal antibodies against influenza A(H7N9) virus infection","author":"Wan","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0435","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41564-017-0011-8","article-title":"Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes","volume":"2","author":"Wohlbold","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coi.2018.03.025_bib0440","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JVI.01756-15","article-title":"Comparative efficacy of monoclonal antibodies that bind to different epitopes of the 2009 pandemic H1N1 influenza virus neuraminidase","volume":"90","author":"Jiang","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0445","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of neuraminidase antibody on Hong Kong influenza","volume":"1","author":"Monto","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2018.03.025_sbref0450","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.coi.2018.03.025_bib0455","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/CVI.00604-15","article-title":"Correlates of protection against influenza in the elderly: results from an influenza vaccine efficacy trial","volume":"23","author":"Dunning","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2018.03.025_sbref0460","doi-asserted-by":"crossref","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.coi.2018.03.025_bib0465","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/381123","article-title":"Protection of mice with recombinant influenza virus neuraminidase","volume":"189","author":"Kilbourne","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.03.025_sbref0470","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1016\/j.vaccine.2015.08.005","article-title":"Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge","volume":"33","author":"Kingstad-Bakke","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0475","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.virol.2014.12.017","article-title":"Lactococcus lactis displayed neuraminidase confers cross protective immunity against influenza A viruses in mice","volume":"476","author":"Lei","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.03.025_bib0480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virol.2012.06.003","article-title":"Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice","volume":"432","author":"Easterbrook","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.03.025_bib0485","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JVI.02275-15","article-title":"Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice","volume":"90","author":"Wohlbold","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0490","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.virol.2017.08.016","article-title":"An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge","volume":"511","author":"Wilson","year":"2017","journal-title":"Virology"},{"issue":"Suppl.","key":"10.1016\/j.coi.2018.03.025_bib0495","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4161\/hv.7.0.14595","article-title":"An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses","volume":"7","author":"Shoji","year":"2011","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0500","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/jvi.2.8.778-786.1968","article-title":"Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice","volume":"2","author":"Schulman","year":"1968","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0505","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/JVI.00585-15","article-title":"Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza A viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2018.03.025_bib0510","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1086\/657084","article-title":"Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner","volume":"202","author":"Marcelin","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2018.03.025_bib0515","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.03.025_bib0520","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.87.2.786","article-title":"Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins","volume":"87","author":"Kilbourne","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.03.025_bib0525","doi-asserted-by":"crossref","first-page":"20748","DOI":"10.1073\/pnas.1113801108","article-title":"Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses","volume":"108","author":"Sandbulte","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2018.03.025_bib0530","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4049\/jimmunol.99.1.49","article-title":"Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus","volume":"99","author":"Webster","year":"1967","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.03.025_bib0535","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2014.09.003","article-title":"An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera","volume":"210","author":"Couzens","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.coi.2018.03.025_sbref0540","doi-asserted-by":"crossref","DOI":"10.3791\/54573-v","article-title":"Measuring influenza neuraminidase inhibition antibody titers by enzyme-linked lectin assay","author":"Gao","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.coi.2018.03.025_bib0545","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.vaccine.2015.12.022","article-title":"Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity","volume":"34","author":"Eichelberger","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0550","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jviromet.2015.02.014","article-title":"Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses","volume":"217","author":"Westgeest","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.coi.2018.03.025_bib0555","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.virol.2016.10.024","article-title":"Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms","volume":"500","author":"Kosik","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.coi.2018.03.025_bib0560","doi-asserted-by":"crossref","first-page":"e0135474","DOI":"10.1371\/journal.pone.0135474","article-title":"Expression and characterization of recombinant, tetrameric and enzymatically active influenza neuraminidase for the setup of an enzyme-linked lectin-based assay","volume":"10","author":"Prevato","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2018.03.025_bib0565","doi-asserted-by":"crossref","first-page":"e0135383","DOI":"10.1371\/journal.pone.0135383","article-title":"An innovative pseudotypes-based enzyme-linked lectin assay for the measurement of functional anti-neuraminidase antibodies","volume":"10","author":"Prevato","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2018.03.025_sbref0570","first-page":"8","article-title":"Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by Elisa and enzyme inhibition: evidence for original antigenic sin","author":"Rajendran","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coi.2018.03.025_bib0575","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.vaccine.2011.12.056","article-title":"Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry","volume":"30","author":"Williams","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0580","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jviromet.2017.02.015","article-title":"Assessment of influenza A neuraminidase (subtype N1) potency by ELISA","volume":"244","author":"Wan","year":"2017","journal-title":"J Virol Methods"},{"key":"10.1016\/j.coi.2018.03.025_bib0585","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.vaccine.2014.01.078","article-title":"Stability of neuraminidase in inactivated influenza vaccines","volume":"32","author":"Sultana","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2018.03.025_bib0590","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vaccine.2012.10.065","article-title":"Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines","volume":"31","author":"Couch","year":"2012","journal-title":"Vaccine"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095279151830027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095279151830027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:43:29Z","timestamp":1760604209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095279151830027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":59,"alternative-id":["S095279151830027X"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2018.03.025","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2018.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}